- Home
- GPOR vs VKTX Comparison
GPOR vs VKTX Comparison
Compare GPOR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GPOR | VKTX |
|---|---|---|
| Founded | 1997 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.3B |
| IPO Year | 1998 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GPOR | VKTX |
|---|---|---|
| Price | $162.87 | $38.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $233.33 | $95.86 |
| AVG Volume (30 Days) | 255.6K | ★ 2.5M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 245.92 | N/A |
| EPS | ★ 8.87 | N/A |
| Revenue | ★ $1,422,583,000.00 | N/A |
| Revenue This Year | $18.35 | N/A |
| Revenue Next Year | $6.04 | N/A |
| P/E Ratio | $17.97 | ★ N/A |
| Revenue Growth | ★ 48.47 | N/A |
| 52 Week Low | $158.91 | $22.96 |
| 52 Week High | $225.78 | $43.15 |
Technical Indicators
Market Signals| Indicator | GPOR | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 38.48 | 73.64 |
| Support Level | N/A | $33.65 |
| Resistance Level | $172.13 | $39.78 |
| Average True Range (ATR) | 4.47 | 1.92 |
| MACD | 0.43 | 1.07 |
| Stochastic Oscillator | 24.06 | 87.55 |
Price Performance
Historical ComparisonAbout GPOR Gulfport Energy Corporation
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets located in the Appalachia and Anadarko basins in the United States. The principal properties of the company are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.